Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System
Results reemphasized the persistent public health challenge of pertussis, especially in infants aged 0-5 months. Findings may guide future vaccination policies in Europe.
Authors
- Florence Boisnard
- J. Jund
- Khalil Karzazi
- Juan C. Vargas-Zambrano (ORCID: https://orcid.org/0000-0002-5609-7046)
- C. Janssen
- Denis Macina (ORCID: https://orcid.org/0000-0002-5342-7038)
- Didier Pinquier (ORCID: https://orcid.org/0000-0002-8528-0181)
- Johanna Despres
- Ana Antunes (ORCID: https://orcid.org/0000-0002-1280-6672)
- Régis Verdier
- Mickael Arnaud
Institutions
- IQVIA (United Kingdom) (GB)
- Sanofi (France) (FR)
- Hôpital Charles-Nicolle (FR)
- Centre Hospitalier Annecy Genevois (FR)
- IQVIA (France) (FR)
- IQ Solutions (US)
- Global Vaccines (United States) (US)
- Université de Rouen Normandie (FR)
Publication Details
- Journal
- Journal of Infection and Public Health
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1016/j.jiph.2025.102801
- Citations
- 2
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 2.37
Funders
- Sanofi
- Sanofi Pasteur